Full Text View
Tabular View
No Study Results Posted
Related Studies
Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor
This study is not yet open for participant recruitment.
Verified July 2011 by Capital District Health Authority, Canada
Study NCT01403896   Information provided by Capital District Health Authority, Canada

First Received on July 14, 2011.   Last Updated on July 26, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malignant Lymphoma, Stem Cell Type
Additional conditions recognized in this trial
Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Plerixafor (Mozobil)
Plerixafor + G-CSF
Additional drug interventions recognized in this trial
JM 3100
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Capital District Health Authority, Canada
Genzyme


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services